| NCT Number | NCT06309979 |
| Lead Sponsor | BioMarin Pharmaceutical |
| Conditions | Idiopathic Short Stature |
| Enrollment | 300 participants |
| Start Date | 2024-08-08 |
| Primary Completion | 2040-12-31 (estimated) |
| Study Completion | 2040-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-23 |